N-Acetylneuraminic acid (NeuAc) is widely used
as a supplement to promote brain health and enhance immunity. However,
the low efficiency of de novo NeuAc synthesis limits
its cost-efficient bioproduction. Herein, a synthetic multiplexed
pathway engineering (SMPE) strategy is proposed to improve NeuAc synthesis.
First, we compare the key enzyme sources and optimize the expression
levels of three NeuAc synthesis pathways in Bacillus
subtilis; the AGE, NeuC, and NanE pathways, for which
NeuAc production reached 3.94, 5.67, and 0.19 g/L, respectively. Next,
these synthesis pathways were combined and modularly optimized via
the SMPE strategy, with production reaching 7.87 g/L. Finally, fed-batch
fermentation in a 5 L fermenter reached 30.10 g/L NeuAc production,
the highest reported production using glucose as the sole carbon source.
Using a generally regarded as safe strain as a production host, the
developed NeuAc-producing approach should be favorable for efficient
bioproduction, without the need for plasmids, antibiotics, or chemical
inducers.